<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01153360</url>
  </required_header>
  <id_info>
    <org_study_id>4-2010-0086</org_study_id>
    <nct_id>NCT01153360</nct_id>
  </id_info>
  <brief_title>Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery</brief_title>
  <official_title>Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is planned to medicate oral T3(Liothyronine)to the patients who are planned to
      have OPCAB(off- pump coronary bypass graft surgery. The aim of this study was to assess the
      effects of oral triiodothyronine (T3) therapy on postoperative thyroid hormone
      concentrations, hemodynamic variables and outcomes in patients undergoing OPCAB in a
      randomized, controlled trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>compare the serum T3 concentrations and the number of patients with serum T3 concentrations below the normal range between the groups</measure>
    <time_frame>until 36 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>difference of hemodynamic performance and myocardial injury</measure>
    <time_frame>during surgery and 36 hr after surgery</time_frame>
    <description>difference of hemodynamic performance and myocardial injury between the groups</description>
  </secondary_outcome>
  <other_outcome>
    <measure>major morbidity endpoints including acute renal failure, cardiovascular failure, stroke, mediastinitis, need for ventilator support for &gt;48 h, and new onset atrial fibrillation</measure>
    <time_frame>until discharge of hospital</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Non-thyroidal Illness Syndrome</condition>
  <arm_group>
    <arm_group_label>T3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>triiodothyronine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cyanocobalamin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vitamin B12</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>liothyronine sodium</intervention_name>
    <description>liothyronine sodium 20ug, every 12hour (before anesthetic induction, total 4 times)</description>
    <arm_group_label>T3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>vitamin B12</description>
    <arm_group_label>cyanocobalamin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are undergoing Off-pump coronary artery bypass graft

        Exclusion Criteria:

          -  No normal sinus rhythm,

          -  History of thyroid disease

          -  Abnormal thyroid hormone

          -  Renal dysfunction

          -  Hepatic dysfunction

          -  LVEF &lt;30%

          -  Recent MI

          -  Active infection 1~15
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yong-Sun Choi, MD, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesiology &amp; Pain Medicine, Severance Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2010</study_first_submitted>
  <study_first_submitted_qc>June 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2010</study_first_posted>
  <last_update_submitted>July 23, 2012</last_update_submitted>
  <last_update_submitted_qc>July 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yonsei University</investigator_affiliation>
    <investigator_full_name>Yong-Sun Choi</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Euthyroid Sick Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

